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Abstract
Background Various techniques of laparoscopic Roux-en-Y
gastric bypass have been described. We completely stan-
dardized this procedure to minimize its sometimes substan-
tial morbidity and mortality. This study describes our
experience with the standardized fully stapled laparoscopic
Roux-en-Y gastric bypass (FS-LRYGB) and its influence
on the 30-day morbidity and mortality.
Methods We retrospectively analyzed 2,645 patients who
underwent FS-LRYGB from May 2004 to August 2008.
Operative time, hospital stay and readmission, re-operation,
and 30-day morbidity/mortality rates were then calculated.
The 30-day follow-up data were complete for 2,606
patients (98.5%).
Results There were 539 male and 2,067 female patients.
Mean age was 39.2 years (range 14–73), mean BMI
41.44 kg/m
2 (range, 23–75.5). The mean hospital stay was
3.35 days (range 2–71). Mean total operative time was
63 min (range 35–150).
One patient died of pneumonia within 30 days of surgery
(0.04%). One hundred and fifty one (5.8%) patients had
postoperative complications as follows: gastrointestinal
hemorrhage (n=89, 3.42%), intestinal obstruction (n=9,
0.35%), anastomotic leak (n=5, 0.19%) and others (n=47,
1.80%). In 66 patients, the bleeding resolved without any
surgical re-intervention. One hemorrhage resulted in hypo-
volemic shock with subsequent renal and hepatic failure.
Conclusion The systematic approach and the full standard-
ization of the FS-LRYGB procedure contribute highly to
the very low mortality and the low morbidity rates in our
institution. Gastrointestinal bleeding appears to be the
commonest complication, but is self-limiting in the majority
of cases. Our approach also significantly reduces operative
time and turns the technically demanding laparoscopic
Roux-en-Y gastric bypass procedure into an easy repro-
ducible operation, effective for training.
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Obesity is a chronic disease and is associated with an
increased risk of co-morbidities and mortality. The World
Health Organization has declared obesity as the epidemic of
the twenty-first century. An estimated 300 million people
worldwide are obese [1]. More than 65% of Americans are
overweight. Of these, 30% are obese and 4.9% are
extremely obese [2].
In Europe, the prevalence of obesity (body mass index
≥30 kg/m
2) in men range from 4.0% to 28.3% and in
women from 6.2% to 36.5% [3].
In 1991, a consensus was reached by the National
Institutes of Health stating that surgical treatment offers the
best long-term results [4]. Bariatric surgery is effective in
reducing obesity related co-morbidities as well as achieving
major long-term weight loss and improvement in quality of
life. Furthermore, loss of excess weight leads to an almost
normal life expectancy [5, 6]. Compared with conservative
management, bariatric surgery leads to a 29% reduction in
the long-term risk of death [7].
Bariatric operations are classified as either restrictive or
malabsorptive. Roux-en-Y gastric bypass (RYGB) combines
both mechanisms. The first gastric bypass was reported in
1967byMasonandIto[8]. Wittgrove and Clark were the first
to report the laparoscopic procedure in 1994 [9]. The RYGB
has steadily gained increasing popularity and is now the most
common bariatric operation worldwide [10]. The laparoscop-
ic approach has a clear advantage over the traditional open
one including better visualization of the operative field,
decreased pain, lower incidence of wound-related and
abdominal wall complications, better cosmetic results, faster
recovery, and shorter hospital stay. The 5-year weight-loss
rate and the resolution of co-morbidities are similar [11, 12].
The Department of General Surgery in AZ Sint-Jan
Hospital AV in Bruges is a referral center with a specific
unit dedicated to the treatment of morbid obesity. Approx-
imately 1,000 obese patients are treated each year. The
objective of this study was to evaluate the impact of the
total standardization and the full stapling of the laparoscop-
ic RYGB procedure on the 30-day morbidity and mortality.
Materials and Methods
This is a retrospective study of a prospectively kept
database of all the patients undergoing fully stapled
laparoscopic Roux-en-Y gastric bypass (FS-LRYGB) in a
standardized fashion by a single surgeon or under his direct
supervision, from May 3rd 2004 to August 31st 2008.
Patient data were collected from the hospital’s electronic
medical record and by telephone interview. The data
included patient demographics, body mass index, operative
times, length of stay, technical details, and 30-day read-
mission, re-operation, morbidity, and mortality rates.
Data are expressed as mean for continuous variables or
as percentage for categorical data, and were analyzed using
Excel 2007 for Windows XP.
Operation Technique
Anesthesia
No premedication was given. One dose of cefazoline 1 g
was given IV at induction. General anesthesia was induced
with IV sufentanil and propofol, followed by IV cis-
atracurium to facilitate endotracheal tube placement and
pneumoperitoneum inflation. General anesthesia was main-
tained with incremental IV bolus of sufentanil, cisatracu-
rium, and inhalation of desflurane as required. Standard
physiologic monitoring included electrocardiograph, pulse
oximetry, and non-invasive arterial blood pressure.
All the patients were ventilated mechanically at a 50%
inspired oxygen fraction (FIO2) and a positive end-
expiratory pressure around 5 cmH2O, using a volume or a
pressure controlled setting. Patients were ventilated at an
elevated EtCO2 level to improve blood pressure and skin
perfusion [13, 14].
Patient Positioning and Trocar Placement
The patient is placed in the supine position, split-leg with
reverse Trendelenburg position. All patients get a flexion of
the hips to help increase surgical abdominal workspace
[15]. The surgeon stands between the legs. A video monitor
is positioned at the level of the patient’s head. A 30° angle
scope is used. Abdominal insufflation with carbon dioxide
(CO2) is achieved using a Veress needle. Intra-abdominal
pressures are maintained at 15 mmHg.
A five-port technique is employed: a 10 mm port 10–
15 cm below the xiphoid process, a 5 mm port high
epigastric on the midline, a 12-mm port in the right upper
quadrant and two 12 mm ports in the left upper quadrant.
The latter two ports are placed on the same line of the
10 mm port, while the former 12 mm port is placed
somewhat higher above the same line (sub costal) (Fig. 1).
Creation of the Gastric Pouch
A small window is made between the lesser omentum and
the lesser curvature of the stomach, entering the lesser sac
5–6 cm below the gastro-esophageal junction (Fig. 2a). At
this point a linear stapler (EndoGia Universal Stapler
System, Covidien, USA or Echelon 60 Endopath Stapler,
Ethicon, USA), usually with a blue cartridge, is introduced
through this window and the stomach horizontally cut over
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stapler is then introduced and fired to vertically transect the
stomach using a 34 Fr. orogastric tube as a guide (Fig. 2c).
The next step consists of dissection and opening of the
angle of His. Posterior to the stomach the dissection is
completed to create a window at the angle of His. Finally,
the pouch is completed by vertically firing one or two more
60 mm cartridges in the direction of and through the latter
created window, along the gastric tube (Fig. 2d).
Creation of the Gastro-jejunostomy
A smallopeningismadeinthelower left cornerofthepouch,
the opening stretched and a purse-string suture is sewn using
an absorbable monofilament suture (PDS II 3/0, Ethicon,
USA;Fig.3a–b). A 25-mm Premium Plus CEEA (Covidien,
USA) is then introduced intra-abdominally via the most left
lateral, manually-dilated trocar opening. The anvil is
brought into the gastric pouch opening and the purse-
string tied (Fig. 3c). Thereafter, the greater omentum is lifted
and divided up to the left side of the transverse colon. Next,
the ligament of Treitz is identified and a loop of jejunum is
antecolically pulled up from this point to the gastric pouch
(Fig. 3d). An enterotomy is created 30–50 cm from Treitz
and the Premium Plus CEEA introduced over 5–6 cm in the
jejunal loop via this opening in the distal direction. We then
perforate the jejunum under slight traction with the spike,
remove the spike, and connect the stapler to the anvil
(Fig. 4a–c). The anastomosis is completed by closing and
firing the instrument. The remaining small bowel loop with
the previously created opening is then transected 1 cm
proximal to the gastro-jejunostomy using a linear stapler
with a 60-mm white cartridge so as to avoid a long blind
loop of jejunum (Fig. 4d).
Creation of the Jejuno-jejunostomy
The length of the alimentary limb is standard 130 cm. In
patients with BMI >50 kg/m
2, 200 cm is measured and an
antimesenteric opening is created both in the alimentary and
the biliopancreatic limb. A linear 60 mm stapler with a white
cartridge is introduced in both openings in order to establish
a side-to-side anastomosis (Fig. 5a-b). The resulting enter-
otomy defect is lifted by three holding stitches ((PDS II 4/0,
Ethicon, USA) and then longitudinally closed using a similar
stapler (Fig. 5c). The final step is transecting the remaining
blind loop of the biliopancreatic limb, also with a similar
linear stapler, and removal of the piece of bowel (Fig. 5d).
Testing of the Gastro-jejunostomy
A leakage test is done by forcefully injecting methylene
blue through the orogastric tube at the level of the gastro-
jejunostomy anastomosis (Fig. 6). The gastro-jejunostomy
is reinforced if necessary with some additional stitches of
an absorbable monofilament suture (PDS II 4/0, Ethicon,
USA). To prevent postoperative bleeding, all staple lines
are inspected under an elevated systolic arterial pressure
above 140 mmHg [16].
The left lateral trocar port site, which was enlarged to
introduce the Premium Plus CEEA, is closed with the help
of the Endo Close trocar site closure device (Covidien,
USA) to prevent ‘lateral entrapment’ or herniation.
Postoperative Care
On the first postoperative day patients are kept nil by
mouth. No routine upper GI imaging series are performed.
Oral intake is restarted on the second postoperative day and
Fig. 1 Schematic overview of
the trocar positioning and the
different trocar sizes. An over-
view of the different instruments
that are used by each trocar is
depicted in the most right
column
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postoperative day with specific dietary instructions. To
prevent deep venous thrombosis patients receive a daily
subcutaneous injection with low-molecular-weight heparins
for 14 days postoperatively together with elastic compres-
sion stockings. In addition, a proton pump inhibitor
(omeprazole 20 mg) is started and continued for 3 months
to prevent marginal ulcer formation. The first follow-up
visit is scheduled for after 6 weeks. Thereafter, visits are
planned 6, 12, and 24 months postoperatively.
Fig. 2 Creation of the gastric
pouch. a Start of the dissection
at the lesser curvature 5–6c m
below the gastro-esophageal
junction. b The first linear sta-
pler cuts the stomach horizon-
tally. c Vertical transection of the
stomach along a 34 Fr. orogas-
tric tube. d Final stapling at the
angle of His
Fig. 3 Creation of the gastro-
jejunostomy (part 1). a Opening
of the gastric pouch in the lower
left corner. b Purse-string sutur-
ing with PDS 3/0. c Introduction
of the anvil of the circular
stapler and tying of the purse-
string. d Identification of the
angle of Treitz
1358 OBES SURG (2009) 19:1355–1364Fig. 4 Creation of the gastro-
jejunostomy (part 2). a Enter-
otomy 30–50 cm from the angle
of Treitz. b Antimesenteric per-
foration of the jejunum with the
spike after introduction of the
circular stapler. c Closure of the
circular stapler. d Finalization of
the anastomosis by transection
of the remaining small bowel
1 cm proximal to the
gastro-jejunostomy
Fig. 5 Creation of the jejuno-
jejunostomy. a Antimesenteric
opening in the alimentary limb.
b Side-to-side anastomosis with
a linear 60 mm stapler. c Clo-
sure of the enterotomy defect
using three stay sutures. d
Transection of the remaining
blind loop of the biliopancreatic
limb
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Surgical Volume and Patient Characteristics
Between May 2004 and August 2008, 4,732 bariatric
procedures were performed in AZ Sint-Jan Hospital AV
Bruges. Of these, 2,645 were FS-LRYGB, 190 were open
Roux-en-Y gastric bypasses (RYGB), 798 were laparo-
scopic vertical banded gastroplasties (VBG, MacLean),
1,078 were laparoscopic adjustable gastric bandings
(LAGB) and 21 laparoscopic sleeve gastrectomies (LSG).
In-hospital data were collected for all patients. The 30-
day follow-up data were complete for 2606 patients
(98.5%) of the FS-LRYGB group.
The number of FS-LRYGB procedures performed
doubled between 2005 (n=459) to 2007 (n=847). The
female to male ratio was 4:1. The mean age was 39.2 years
(14–73) with 81.3% of patients younger than 50 years of
age and 3.2% of patients older than 60 years. The mean
BMI was 41.44 kg/m
2 with a range from 23 to 75.5 kg/m
2.
Three hundred sixty patients (13.81%) were super-obese
(BMI≥50 kg/m
2) and a total of 53 patients (2.03%) had a
BMI≤30. The latter group (BMI≤30) were all patients that
underwent a conversion from a previous restrictive proce-
dure to a FS-LRYGB. The majority of the patients were
Belgian; the center also has a high referral from the United
Kingdom and the Netherlands (Table 1).
Comorbid Diseases and Previous Surgery
Pre-operative co-morbidities included hypertension (745
cases, 28.59%), gastro-esophageal reflux disease (GERD;
715 cases, 27.44%), dyslipidemia (617 cases, 23.68%),
diabetes mellitus type 2 (239 cases, 9.17%), and sleep
apnea (102 cases, 3.91%) (Table 1).
FS-LRYGB was the primary procedure in 2,353 patients
(90.29%); the remaining underwent a conversion from a
previous restrictive procedure. One hundred eighty-five
patients had previous LAGB, 67 had a VBG and one
patient had a LSG. Overall, 769 patients (29.5%) had
previously undergone non-bariatric abdominal surgery
(other abdominal and/or pelvic operations).
Length of Surgery and Hospital Stay
Mean operative time was 63 min (35–150) and has
importantly decreased in time as the team got more
familiarized with the different standardized steps of the
procedure. The mean length of hospital stay was 3.35 days.
Of the 2,606 patients, 2,197 (84.31%) were discharged on
the third postoperative day or earlier.
No conversions to an open procedure occurred during
the primary procedure. Synchronous procedures included
cholecystectomy in 153 (5.87%), abdominal wall hernia
repair in 13 (0.50%) and Nissen fundoplication in 9
(0.35%) cases.
In-hospital and 30-day Morbidity Rate (Table 2)
Hemorrhage was the most common complication after FS-
LRYGB (89 patients, 3.42%). Early bleeding was recog-
nized by tachycardia, blood pressure drop, hematocrit drop,
oliguria, drain output (in case of extra-luminal bleeding),
hematemesis, and melena (in case of intra-luminal bleeding).
Fig. 6 Testing of the gastro-jejunostomy with methylene blue
Table 1 General patient Characteristics (n=2,606)
Patient Characteristics Variable
Demographics
Mean Age, years 39.2
≥60 84 patients
Sex, F:M 4:1
Mean body mass index (BMI) 41.44
Country of origin
Belgium 1602 (61.47%) patients
Great Britain 358 (13.74%)
Netherlands 335 (12.85%)
Denmark 175 (6.72%)
Norway 35 (1.34%)
Other countries 101 (3.88%)
Co-morbidities
Hypertension 745 (28.59%)
GERD 715 (27.44%)
Hypercholesterolemia 617 (23.68%)
Diabetes type 2 239 (9.17%)
Sleep apnea 102 (3.91%)
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intervention. Of these patients, 46 required transfusions of
blood products and fluids, while 20 others were managed
without blood transfusion. In 23 patients, a laparoscopic re-
operation was necessary to control bleeding. Of these 23
patients, a distinct bleeding source was found and controlled
in 18 patients. In nine patients, the bleeding was extra-
luminal and insixpatientsintra-luminal; intheformergroup,
at a clearly defined spot at the linear gastric staple line in all
cases; in the latter, at the circular anastomotic staple line
construction in all but one. Three patients had a bleeding
from the trocar site or the mesentery of the small bowel. In
five patients, no clear source of bleeding was found during
laparoscopy and cleansing of the abdomen with clot removal
stopped the bleeding. One of these patients later developed a
subphrenic abscess which required re-operation, drainage,
and antibiotic treatment. One hemorrhage resulted in
hypovolemic shock with subsequent multi-organ failure
(hepato-renal and pulmonary failure) and a total hospital
stay of 71 days.
A leak developed in five patients (0.19%) despite a
negative intra-operative methylene blue leakage test. All but
one were male patients. Four leaks were identified inthe early
postoperative phase (postoperative day 2 (n=2) and day 3
(n=2)). One leak was discovered on the 26th day postoper-
atively. Patients were re-operated either laparoscopically
(n=4) or open (n=1). All leaks were anastomotic: four at
the gastro-jejunostomy and one at the jejuno-jejunostomy.
No leaks at the other staple lines were observed.
Small bowel obstruction occurred in nine patients
(0.35%). Seven were secondary to trocar-site hernia
(‘lateral entrapment’). One patient suffered from an incar-
cerated umbilical hernia. One other patient had an obstruc-
tion at the level of the jejuno-jejunostomy due to an acute
anastomotic angulation.
Othercomplications occurred in 47 patients (1.80%). Two
male patients had an iatrogenic pancreatic injury, which
resulted in pancreatitis and was managed by laparoscopic
drainage of the lesser sac.
One male patient developed an iatrogenic small bowel
perforation which was controlled by primary closure of the
perforation.
Other complications included wound infection in 12
(0.46%), fever of unknown origin in nine (0.35%), pneumo-
nia in six (0.23%), urinary tract infection in six (0.23%),
DVT/pulmonary embolism in five (0.19%), early stenosis in
four (0.15%), and cardiac arrhythmia in two (0.08%) cases.
The overall number of re-interventions was 49 on a total
of 41 patients with a resulting re-operation rate of 1.57%.
Five re-operations were performed in patients already
discharged from the hospital. Other 30-day re-admissions
not leading to a re-intervention occurred in 29 patients. This
accounts for a readmission rate of 1.30%.
In-hospital and 30-day Mortality Rate
One patient (male, BMI 51 kg/m
2) died due to pneumonia
and subsequent heart failure on the fourth postoperative
day. This accounts for a 0.04% overall in-hospital and 30-
day mortality rate.
Discussion
The laparoscopic Roux-en-Y gastric bypass is considered
as the golden standard among the surgical bariatric options.
Despite the growing worldwide spread and surgical
experience of this procedure, LRYGB remains a technically
challenging procedure with a substantial morbidity and
mortality.
Buchwald et al. reported in a large meta-analysis a
mortality rate of 0.16% for LRYGB [17]. The mortality rate
in our series was 0.04% which is among the lowest reported
incidences in literature. Flum et al concluded that advanc-
ing age, male sex, and lower surgeon volume are associated
with a higher risk of early death after bariatric surgery [18].
Although the mean BMI of our patient population is rather
low compared to other series, we are convinced that besides
the high patient volume, the full stapling and extensive
standardization of the procedure are the main reasons for
these favorable results. In this standardization, the proce-
dure is split into different phases in which every participant
(surgeon, registrar, scrub nurse, anesthesiologist) has a
specific role. Every single laparoscopic maneuver has been
completely rationalized which contributed to a substantial
shortening of the length of the operative time. One must
fear postoperative leaks as the most important cause of
surgical related mortality. Gastric or intestinal leaks can
Table 2 Incidence of early major postoperative complications
(≤30 days)
Complications No. of cases (%)
Death 1 (0.04%)
Hemorrhage 89 (3.42%)
Blood transfusion 46 (1.77%)
Intestinal obstruction 9 (0.35%)
Pneumonia 6 (0.23%)
Pulmonary emboli and DVT 5 (0.19%)
Anastomotic leak 5 (0.19%)
Anastomotic stenosis and food impaction 4 (0.15%)
Pancreatic injury 2 (0.08%)
Small bowel perforation 1 (0.04%)
Intra-abdominal abscess 1 (0.04%)
OBES SURG (2009) 19:1355–1364 1361result in severe peritonitis, sepsis, and multi-organ failure.
Male gender, re-operation, older age, a BMI >50 kg/m
2
and surgeon experience are all associated with poor
operative outcome and a greater leakage rate [19, 20].
The most common site for an anastomotic leak is the
gastro-jejunostomy [20].
The leakage rate in our series was 0.19% (n=5). One
patient underwent open re-operation and the other four
patients were treated laparoscopically. Different studies report
an overall leakage rate ranging from 0.1% to 5.25% [21–31]
(Table 3). In a review of 6,135 patients in 13 selected series
of laparoscopic RYGB, the mean leakage rate was 1.4%
(range 0–4.3) [20]. The low leakage rate in this study is in
our opinion attributed to a standardized anastomotic tech-
nique with suture reinforcement if necessary and the
construction of a rather long gastric tube. The anastomotic
integrity of the gastro-jejunostomy is intra-operatively
assessed by high-pressure testing of this anastomosis with
methylene blue. The methylene blue test has been reported to
be 100% sensitive and to have no side-effects [32].
We prefer to use the circular stapler to complete the
gastro-jejunostomy. Compared to the linear technique, this
technique does not require closure of a common opening,
eliminating a possible leakage site. Furthermore, traction on
the gastro-jejunostomy is limited due to an equal distribu-
tion of forces on the anastomosis. Additionally, the circular
stapler with a fixed diameter reproduces the opening of the
anastomosis in each case without the subjective sizing of
the other techniques [22].
Insertion of the circular stapler (25 mm Premium Plus
CEEA) with the anvil trans-abdominally is easy, safe and
quick. Passing the anvil into the gastric pouch trans-orally
is an alternative but surgeons should be aware of possible
technical difficulties as hypopharyngeal or esophageal
injury has been described [33, 34].
The technique of the FS-LRYGB in our center involves
the construction of a rather long (5–6 cm) but narrow pouch.
A longer pouch facilitates the construction of the gastro-
jejunostomy importantly and decreases the traction on it,
especially when the alimentary limb is pulled up antecoli-
cally. Capella et al. are convinced that long narrow pouches
are the most effective operations in bariatric surgery. Long
narrow pouches have less tendency to enlarge and delay the
transit of food to a greater degree than wider pouches,
according to the Laplace’s and Poiseuille’s Laws. However,
pouches are not perfect cylinders; the walls are not rigid and
are of variable distensibility. Strict application of these
physical laws to the clinical setting will require further
research [35].
Hemorrhage was the most common in-hospital compli-
cation (3.42%) occurring after FS-LRYGB in our experi-
ence. This number is consistent with the reported 3.1%
incidence by Spaw et al. [36] in a literature review of 2,895
patients. The most common sites of bleeding are the staple
lines which are likely to bleed either extra-luminally (intra-
abdominally) or intra-luminally. At this point, additional
care is taken to identify and control bleedings intra-
operatively. Early recognition of postoperative bleeding is
crucial. Careful clinical and hemodynamic monitoring of the
patient in combination with the observation of the output of
the intra-abdominal drain can avoid hypovolemic shock. In
this study, 74.16% of postoperative bleedings were managed
conservatively without the need of a surgical re-intervention.
More recently, endoscopic management has been introduced
to control bleeding from the gastro-jejunal staple line.
Early stenosis still remains an important issue. Of the
2,606 patients, 4 (0.15%) were re-admitted within 30 days
because of vomiting due to a narrowing of the gastro-jejunal
anastomosis. All cases were treated endoscopically with
balloon dilatation. However, stenosis becomes more appar-
ent after the 30-day period. The overall stenosis rate in our
series with a completed follow-up of 3 months was 0.95%
(n=24 out of 2,521 patients; follow-up rate of 95.3%).
Small bowel obstruction occurred in nine patients
(0.35%) and nearly all were related to hernias. Seven out of
nine patients had a lateral entrapment at the left lateral trocar
1st Author, year No. of cases Overall anastomotic leakage rate (%)
Carrasquilla [22], 2004 1,000 0.1
Agaba [31], 2008 1,364 0.15
Durak [27], 2008 1,133 1.5
Gonzalez [26], 2007 3,018 2.1
Madan [23], 2006 300 3.0
Lee [24], 2007 3,828 3.9
Hamilton [25], 2003 210 4.3
Ballesta [30], 2008 1,200 4.9
DeMaria [28], 2002 281 5.1
Marshall [21], 2003 400 5.25
Carucci [29], 2006 904 5.3
Table 3 Comparative overall
leakage rate after Roux-en-Y
gastric bypass
1362 OBES SURG (2009) 19:1355–1364site and required re-operation. This problem has now been
overcome by using standard direct visual closure of the
trocar site with the Endo Close (Covidien, USA) system.
In the past, we did not close Petersen’s space. Although
the antecolic antegastric technique has the least incidence of
internal hernias, we have, as of March 2008, started closing
Petersen’s space. To date, there is sufficient data suggesting
that this closure is better done on a routine basis [37–39].
However, recently, Madan et al. [40] suggest that manda-
tory closure of mesenteric defects might potentially create
an increased risk of complications and costs without a real
added benefit for the patient.
In this study, the re-operation rate was 1.57% and the
readmission rate 1.30%.
In other publications, readmission rates after gastric
bypass range from 0.6% to 6.6% [41–44]. A nationwide in-
patient sample estimated that the rates of unexpected re-
operation during the same admission ranged from 6 to 9%
[45].
Conclusion
The fully stapled laparoscopic Roux-en-Y gastric bypass
(FS-LRYGB) is a safe and easy reproducible surgical
weight-loss procedure. Maximal standardization of the
operation and high surgical volume contributed both to
the very low 30-day morbidity and mortality rate in our
series. Postoperative bleeding was the commonest compli-
cation that in most cases could be treated conservatively.
Further refinements in the stapling devices are mandatory to
decrease this incidence in the future.
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